Characterization of a Carbapenem-Resistant BKC-1-Producing Clinical Isolate Belonging to the Pseudomonas putida Group from Brazil.

Antimicrob Agents Chemother

Universidade Federal de São Paulo, Laboratório ALERTA, Division of Infectious Diseases, Department of Internal Medicine, Escola Paulista de Medicina, São Paulo, São Paulo, Brazil.

Published: December 2022

Since its first report, the class A Brazilian Klebsiella carbapenemase (BKC) has been detected only among isolates from Brazilian hospitals. In this study, we characterized a multidrug-resistant Pseudomonas juntendi clinical isolate and identified a 43.3-kb plasmid carrying and a class 1 integron (In) containing the , , , and gene cassettes. Our results confirm the ability of Pseudomonas putida group isolates to acquire antimicrobial resistance determinants and further act as resistance reservoirs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765262PMC
http://dx.doi.org/10.1128/aac.00839-22DOI Listing

Publication Analysis

Top Keywords

clinical isolate
8
pseudomonas putida
8
putida group
8
characterization carbapenem-resistant
4
carbapenem-resistant bkc-1-producing
4
bkc-1-producing clinical
4
isolate belonging
4
belonging pseudomonas
4
group brazil
4
brazil report
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!